Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,796,239
-$1,202,018 QoQ
Shares Held
256,790
-2.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#322
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. BMY ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,796,239 | 256,790 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $15,998,257 | 263,780 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,866,451 | 294,150 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $13,590,885 | 301,350 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,949,491 | 301,350 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $19,428,364 | 318,550 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,836,196 | 315,350 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,322,552 | 334,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,218,668 | 366,450 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,477,791 | 396,050 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,792,190 | 463,695 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,983,376 | 464,910 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $30,955,637 | 484,060 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $34,003,486 | 490,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $35,091,813 | 487,725 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,882,085 | 490,675 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,339,146 | 510,898 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $38,270,495 | 524,038 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $34,142,111 | 547,588 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,522,445 | 617,246 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $43,243,364 | 647,162 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $41,068,716 | 650,542 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $38,415,179 | 619,300 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $41,976,912 | 696,250 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $43,350,300 | 737,250 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $64,801,094 | 1,162,560 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||